Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Cash Flow Reinvestment Rate
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Reinvestment Rate of 0.50x as of December 2024, reinvesting CN¥57.97 Million (capex CN¥33.16 Million plus investments CN¥24.80 Million) from operating cash flow of CN¥116.38 Million. Check cash flow quality index of Medprin Regenerative Medical Technologie to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Explore 301033 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Medprin Regenerative Medical Technologies Co. Ltd.. For live market cap and broader valuation context, see Medprin Regenerative Medical Technologie stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | CN¥57.97 Million | CN¥116.38 Million | CN¥33.16 Million | ▼ -34.5% |
| 2023 | 0.76x | CN¥81.93 Million | CN¥107.69 Million | CN¥40.09 Million | ▼ -76.2% |
| 2022 | 3.20x | CN¥154.51 Million | CN¥48.31 Million | CN¥135.96 Million | ▼ -54.5% |
| 2021 | 7.03x | CN¥467.64 Million | CN¥66.51 Million | CN¥152.71 Million | ▲ +55.4% |
| 2020 | 4.52x | CN¥153.41 Million | CN¥33.91 Million | CN¥61.65 Million | ▲ +9.7% |
| 2019 | 4.13x | CN¥129.03 Million | CN¥31.27 Million | CN¥36.71 Million | — |